Shares of Sequenom, Inc. (NASDAQ:SQNM) closed at $2.38 with 1.47 million shares getting traded. Post opening the session at $2.38, the shares hit an intraday low of $2.38 and an intraday high of $2.39 and the price vacillated in this range throughout the day. The company has a market cap of $283.80 million and the numbers of outstanding shares have been calculated to be 119.24 million shares.
Sequenom, Inc. (SQNM) announced on July 27, 2016 that it entered into a definitive agreement and plan of merger with Laboratory Corporation of America® Holdings (LabCorp®) under which LabCorp would acquire all of the outstanding shares of Seqeunom in a cash tender offer.
Shares of Relypsa Inc (NASDAQ:RLYP) closed at $31.96 with 1.55 million shares getting traded. Post opening the session at $31.98, the shares hit an intraday low of $31.95 and an intraday high of $31.99 and the price vacillated in this range throughout the day. The company has a market cap of $1.43 billion and the numbers of outstanding shares have been calculated to be 44.88 million shares.
Relypsa Inc (RLYP) a biopharmaceutical company, focuses on the discovery, development, and commercialization of polymeric medicines for patients with conditions that are overlooked and undertreated and can be addressed in the gastrointestinal tract primarily in the United States. The company offers Veltassa (patiromer), a non-absorbed potassium binding polymer for the treatment of hyperkalemia. It has license agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. for developing and commercializing Veltassa outside the United States and Japan. The company was founded in 2007 and is headquartered in Redwood City, California.